All News

2057 articles, sorted by publication time.

Biotechnology and Pharmaceuticals · global

Harnessing Cells to Clear Disease-Causing Proteins: Protein Degrader Drugs Move Toward Clinical Validation

Protein degradation technology, drawing heavy investment from drugmakers, is building treatment evidence in multiple myeloma. One combination therapy has received U.S. accelerated approval, while another has entered regulatory review; how far this new approach can go still depends on whether efficacy is sustained and the safety costs of clearing proteins.